[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone

C80H71Br2I2N21O7 — CID 157300917

About [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone

[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone (PubChem CID 157300917) has the molecular formula C80H71Br2I2N21O7 and a molecular weight of 1852.20 g/mol. Its IUPAC name is [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone.

Molecular Properties

• Compound Name: [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone
• PubChem CID: 157300917
• Molecular Formula: C80H71Br2I2N21O7
• Molecular Weight: 1852.20 g/mol
• Exact Mass: 1849.23
• IUPAC Name: [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone
• SMILES: CN1CCN(C(=O)c2ccc(-c3cn4c(Br)cnc4cn3)cc2)CC1.CN1CCN(C(=O)c2ccc(-c3cn4c(I)cnc4cn3)cc2)CC1.CN1CCN(C(=O)c2ccc(-c3cn4ccnc4cn3)cc2)CC1.O=COc1ccc(-c2cn3c(Br)cnc3cn2)cc1.O=COc1ccc(-c2cn3c(I)cnc3cn2)cc1
• InChI: InChI=1S/C18H18BrN5O.C18H18IN5O.C18H19N5O.C13H8BrN3O2.C13H8IN3O2/c2*1-22-6-8-23(9-7-22)18(25)14-4-2-13(3-5-14)15-12-24-16(19)10-21-17(24)11-20-15;1-21-8-10-22(11-9-21)18(24)15-4-2-14(3-5-15)16-13-23-7-6-19-17(23)12-20-16;2*14-12-5-16-13-6-15-11(7-17(12)13)9-1-3-10(4-2-9)19-8-18/h2*2-5,10-12H,6-9H2,1H3;2-7,12-13H,8-11H2,1H3;2*1-8H
• InChIKey: BBWSILANYVVVGJ-UHFFFAOYSA-N
• XLogP: 11.95
• TPSA: 274.20 Ų
• H-Bond Acceptors: 25
• Rotatable Bonds: 12
• Heavy Atoms: 112
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1852.20
LogP ≤ 5	11.95
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	25

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone?

The IUPAC name of [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone (CID 157300917) is [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone.

What is the SMILES notation for [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone?

The canonical SMILES for [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone is CN1CCN(C(=O)c2ccc(-c3cn4c(Br)cnc4cn3)cc2)CC1.CN1CCN(C(=O)c2ccc(-c3cn4c(I)cnc4cn3)cc2)CC1.CN1CCN(C(=O)c2ccc(-c3cn4ccnc4cn3)cc2)CC1.O=COc1ccc(-c2cn3c(Br)cnc3cn2)cc1.O=COc1ccc(-c2cn3c(I)cnc3cn2)cc1.

What is the InChIKey of [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone?

The InChIKey is BBWSILANYVVVGJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H18BrN5O.C18H18IN5O.C18H19N5O.C13H8BrN3O2.C13H8IN3O2/c2*1-22-6-8-23(9-7-22)18(25)14-4-2-13(3-5-14)15-12-24-16(19)10-21-17(24)11-20-15;1-21-8-10-22(11-9-21)18(24)15-4-2-14(3-5-15)16-13-23-7-6-19-17(23)12-20-16;2*14-12-5-16-13-6-15-11(7-17(12)13)9-1-3-10(4-2-9)19-8-18/h2*2-5,10-12H,6-9H2,1H3;2-7,12-13H,8-11H2,1H3;2*1-8H.

What are the key properties of [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone?

[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone has a molecular weight of 1852.20 g/mol, XLogP of 11.95, 12 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.

Where does this data come from?

All data for [4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-bromoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone;(4-imidazo[1,2-a]pyrazin-6-ylphenyl)-(4-methylpiperazin-1-yl)methanone;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl] formate;[4-(3-iodoimidazo[1,2-a]pyrazin-6-yl)phenyl]-(4-methylpiperazin-1-yl)methanone is sourced from PubChem (CID 157300917), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).